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Blast-induced traumatic brain injury (TBI) has been a major cause of morbidity and mortality
in the conflicts in Iraq and Afghanistan. How the primary blast wave affects the brain is not
well understood. In particular, it is unclear whether blast injures the brain through mecha-
nisms similar to those found in non-blast closed impact injuries (nbTBI).The β-amyloid (Aβ)
peptide associated with the development of Alzheimer’s disease is elevated acutely follow-
ingTBI in humans as well as in experimental animal models of nbTBI. We examined levels
of brain Aβ following experimental blast injury using enzyme-linked immunosorbent assays
for Aβ 40 and 42. In both rat and mouse models of blast injury, rather than being increased,
endogenous rodent brain Aβ levels were decreased acutely following injury. Levels of the
amyloid precursor protein (APP) were increased following blast exposure although there
was no evidence of axonal pathology based on APP immunohistochemical staining. Unlike
the findings in nbTBI animal models, levels of the β-secretase, β-site APP cleaving enzyme
1, and the γ-secretase component presenilin-1 were unchanged following blast exposure.
These studies have implications for understanding the nature of blast injury to the brain.
They also suggest that strategies aimed at lowering Aβ production may not be effective for
treating acute blast injury to the brain.
Keywords: abeta, amyloid precursor protein, β-siteAPP cleaving enzyme 1, blast, mouse, presenilin-1, rat, traumatic
brain injury
INTRODUCTION
Blast-induced brain injury has been of longstanding interest in
military head trauma (Jones et al., 2007). Recently, there has been
renewed interest in blast related traumatic brain injury (TBI)
because of the frequency of blast injury in the conflicts in Iraq and
Afghanistan (Elder et al., 2010). How the primary blast wave itself
affects the brain (as differentiated from the deceleration injury
where the brain is injured by a person hitting an object, such as
a wall or the ground) is not well understood (Cernak and Noble-
Haeusslein, 2010). Direct tissue damage, bleeding, and diffuse
axonal injury (DAI) are the best known pathophysiological mech-
anisms associated with the type of blunt impact injuries that occur
in most non-blast closed impact injuries (nbTBI; Gennarelli and
Grahm, 2005). However, whether blast injures the brain through
mechanisms similar to those found in nbTBI is unknown.
Several proteins associated with neurodegenerative diseases
accumulate in brain following nbTBI, including α-synuclein, tau,
the amyloid precursor protein (APP), and its product the β-
amyloid (Aβ) protein (Uryu et al., 2007). Accumulation of Aβ
protein is most associated with the development of Alzheimer’s
disease (AD), and there has been much interest in whether its
upregulation following TBI may explain the epidemiological asso-
ciation between a history of prior TBI and the subsequent devel-
opment of AD (DeKosky et al., 2010; Johnson et al., 2010). Indeed,
changes in Aβ occur rapidly after acute TBI; diffuse cortical Aβ
deposits and increased levels of soluble Aβ have been observed
in humans as early as 2 h after a severe TBI (Ikonomovic et al.,
2004; DeKosky et al., 2007, 2010; Johnson et al., 2010). There is
also a well-documented synergy between TBI and outcome of TBI
in carriers of the apolipoprotein E ε4 allele (Mayeux et al., 1995;
Zhou et al., 2008), a connection that suggests some role for Aβ in
TBI outcome.
Elevations of Aβ have also been seen acutely in many (Smith
et al., 1998; Abrahamson et al., 2009; Loane et al., 2009, 2011; Tran
et al., 2011; Tian et al., 2012; Yu et al., 2012; Zhang et al., 2012)
although not all (Schwetye et al., 2010) experimental animal mod-
els of nbTBI, along with increased expression of components of
the γ-secretase complex as well as β-site APP cleaving enzyme 1
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(BACE1), the principal β-secretase (Blasko et al., 2004; Chen et al.,
2004; Nadler et al., 2008; Loane et al., 2009; Zohar et al., 2011).
These observations are all consistent with increased processing of
APP (producing increased Aβ) after TBI. Studies in nbTBI animal
models also consistently reveal increased APP expression acutely
following TBI (Murakami et al., 1998; Van Den Heuvel et al., 2000;
Ciallella et al., 2002; Chen et al., 2004).
All prior studies examining Aβ levels in experimental animals
have been performed using models that mimic the types of con-
tusional and diffuse brain injuries associated with nbTBI closed
impact head injury (Abrahamson et al., 2009; Loane et al., 2009,
2011; Schwetye et al., 2010; Tran et al., 2011; Tian et al., 2012; Yu
et al., 2012; Zhang et al., 2012). Whether blast TBI activates pri-
mary and secondary cascades similar to those activated in nbTBI
is unknown. In ongoing studies we have been examining the acute
effects of blast in rat and mouse models (Wang et al., 2011; Ahlers
et al., 2012; Elder et al., 2012). During the course of these studies
frozen brain tissue was collected across a range of blast exposures
corresponding to a spectrum of mild to severe TBI in the rat and
severe TBI in the mouse. Here we took advantage of the availability
of this tissue to examine levels of brain Aβ following experimental
blast injury.
MATERIALS AND METHODS
ANIMALS
Adult male Long Evans Hooded rats (250–350 g; 10–12 weeks age;
Charles River Laboratories International, Inc., Wilmington, MA,
USA) or C57BL/6 mice (8–10 weeks old; 22–26 g; Jackson Labo-
ratories, Bar Harbor, ME, USA) were used as subjects. All studies
were approved by the Institutional Animal Care and Use Commit-
tees of the Naval Medical Research Center, the Walter Reed Army
Institute of Research (WRAIR), and the James J. Peters VA Medical
Center.
BLAST OVERPRESSURE EXPOSURE
Rats were subjected to overpressure exposure using the WRAIR
shock tube which simulates the effects of air blast exposure under
experimental conditions. The shock tube has a 12′′ circular diame-
ter and is a 19.5-ft long steel tube divided into a 2.5-ft compression
chamber that is separated from a 17-ft expansion chamber. The
compression and expansion chambers are separated by polyeth-
ylene Mylar™sheets (Du Pont, Co., Wilmington, DE, USA) that
control the peak pressure generated (Chavko et al., 2007; Elder
et al., 2010). The peak pressure at the end of the expansion cham-
ber was determined by piezoresistive gages specifically designed for
pressure-time (impulse) measurements (Model 102M152, PCB,
Piezotronics, Inc., Depew, NY, USA).
Individual rats were anesthetized using an isoflurane gas anes-
thesia system consisting of a vaporizer, gas lines and valves, and
an activated charcoal scavenging system adapted for use with
rodents. Rats were placed into a polycarbonate induction cham-
ber, which was closed and immediately flushed with 5% isoflurane
mixture in air for 2 min. Rats were placed into a cone shaped
plastic restraint device and then placed in the shock tube. Move-
ment was further restricted during the blast exposure using 1.5 cm
diameter flattened rubber tourniquet tubing. Three tourniquets
were spaced evenly to secure the head region, the upper torso,
and lower torso while the animal was in the plastic restraint cone.
The end of each tubing was threaded through a toggle and run
outside of the exposure cage where it was tied to firmly affix the
animal and prevent movement during the blast overpressure expo-
sure without restricting breathing. Rats were assigned randomly
to sham or blast condition without any body shielding, result-
ing in full body exposure to the blast wave with the head, upper
torso, and lower torso fixed in a plastic restraint cone. Two body
orientations were tested – with the rat’s head facing toward or
sideways (at a right angle to the wave, counterbalanced left and
right) to the blast wave. Blast exposed animals received single
36.6 (n= 15), 74.5 (n= 26), or 116.7 (n= 19) kilopascal (kPa)
exposures. Sham exposed animals (n= 9) were treated identically
except that they did not receive a blast exposure. Mice (n= 6 blast
and 6 control) were treated in a similar manner and received
a single 147 kPa blast exposure with the head perpendicular to
the direction of the blast wave in a prone position (Wang et al.,
2011).
ENZYME-LINKED IMMUNOSORBENT ASSAYS FOR ABETA
Animals were euthanized by CO2 narcosis or decapitation after
isoflurane anesthesia and the brains were quickly removed, frozen,
and stored at −80˚C until use. Triton X-100 fractions from one
hemisphere in the case of rats, or whole brain in the case of mice,
were prepared using a protocol adapted from that described in
Kawarabayashi et al. (2001) and described in more detail by Steele
et al. (2009). The tissues were homogenized with a hand held
homogenizer in 50 mM Tris-HCl buffer, pH 7.4, 150 mM NaCl, 1%
Triton X-100 buffer supplemented with a protease/phosphatase
inhibitor cocktail (Sigma Aldrich, St. Louis, MO, USA) at a con-
centration of 0.2 mg fresh tissue/ml of buffer. The homogenates
were centrifuged at 100,000× g for 1 h at 4˚C. The supernatants
were decanted and Aβ 40 and 42 levels were determined by
Enzyme-linked immunosorbent assays (ELISAs) using a commer-
cially available kit that detects rodent Aβ (Wako, Richmond, VA,
USA). The pellets were then extracted in the above buffer contain-
ing 0.25% Na deoxycholate and 0.5% SDS, centrifuged and the
supernatant saved (SDS extract).
WESTERN BLOTTING
Protein samples (Triton X-100 extracts for APP and BACE1; SDS
extracts for presenilin-1) were separated by SDS-PAGE and blot-
ted onto polyvinylidene difluoride (PVDF) membranes (Millipore
Corporation, Billerica, MA, USA). The primary antibodies utilized
were a mouse monoclonal anti-APP (1:1500; Mab348, Millipore
Corp.), a rabbit polyclonal anti-BACE1 (1:1500; Millipore Corp.),
a rabbit polyclonal anti-β-tubulin antibody (1:4000; Abcam, Cam-
bridge, UK) and the mouse monoclonal antibody 33B10 against
the C-terminal fragment of presenilin-1 (1:2000; gift of Dr. Niko-
laos Robakis, Mount Sinai School of Medicine, New York, NY,
USA). The membranes were probed with the appropriate HRP-
conjugated secondary antibodies (GE Life Sciences, Piscataway,
NJ, USA), and the protein bands were visualized with the ECL
Prime reagent (GE Life Sciences). For reprobing, the membranes
were treated with Re-Blot Plus strong stripping solution (Millipore
Corp.) according to the manufacturer’s instructions. Quantifi-
cation was performed using Image Quant TL software (GE Life
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Sciences). Levels of the target proteins were normalized to levels
of β-tubulin.
IMMUNOHISTOCHEMISTRY
Rats were perfused with 4% paraformaldehyde in phosphate
buffered saline (PBS). The brains were dissected and cut into
50µm thick sections using a Vibratome (Leica, Wetzlar, Ger-
many). Immunohistochemical staining was performed as previ-
ously described (Gama Sosa et al., 2010) using a rabbit anti-APP
antibody APP369 (1:700), which recognizes the APP C-terminus
and detects full-length APP and C-terminal fragments of APP
(Keilani et al., 2012) and SMI-31, a mouse monoclonal antibody
that recognizes phosphorylated epitopes on the mouse mid-sized
and heavy neurofilament proteins (1:500; Covance, Denver, PA,
USA).
STATISTICAL ANALYSIS
Depending on the experiment, statistical tests employed uni-
variate or factorial analysis of variance (ANOVA), or unpaired
t -tests. Equality of variance was first assessed using the Levene test.
When the Levene test was not significant (comparisons yielding
p> 0.05), between-group comparisons were made using unpaired
t -tests (Student’s), and univariate or factorial ANOVA. Post hoc
comparisons following univariate ANOVA were performed using
Dunnett’s test with sham exposed controls treated as the refer-
ence group. When the Levene statistic was significant (p< 0.05),
unpaired t -tests were employed using the Welch correction for
unequal variances. Statistical tests were performed using SPSS
20.0 (SPSS, Chicago, IL, USA) or GraphPad Prism 5.0 (GraphPad
Software, San Diego, CA, USA).
RESULTS
DECREASED LEVELS OF Aβ IN RATS EXPOSED TO BLAST
OVERPRESSURE INJURY
We utilized a rat model of TBI in which adult male rats received
single 36.6, 74.5, or 116.7 kPa exposures. The physical character-
istics of the blast wave have been previously described (Ahlers
et al., 2012) and a representative tracing of a 36.6 kPa blast wave
exposure is shown in Figure 1. Two body orientations were tested
with the rats facing toward or sideways (counterbalanced left and
right) to the blast wave with the head and body fixed in a plastic
restraint cone to restrict movement. Rats were sacrificed either 24 h
or 1 week after receiving the blast exposure and Triton X-100 frac-
tions were prepared from one hemisphere using a protocol adapted
from Kawarabayashi et al. (2001). In preliminary studies we found
that most rat Aβ 40 and 42 were found in the Triton X-100 sol-
uble fraction, compared to the Tris buffered saline and formic
acid-extractable fractions (Figure A1 in Appendix). Therefore, for
these studies, the Triton X-100 fraction was analyzed.
Initially we examined all body orientations to blast together
in one pooled analysis. A univariate ANOVA showed that Aβ 42
levels were significantly different from controls (F6, 62= 5.911;
p< 0.001). The effect of acute blast exposure on brain Aβ lev-
els at each blast level is shown in Figure 2 and Table 1. Compared
to sham exposed controls, the 36.6 kPa exposure at 24 h (p= 0.002,
Dunnett’s test) and 1 week (p= 0.005) as well as the 74.5 kPa
exposure at 24 h (p= 0.002) resulted in significantly lower lev-
els of Aβ 42. In the 74.5 kPa exposure at 1 week, the level of
FIGURE 1 | A representative tracing of a 36.6 kPa blast wave exposure
is shown. The red line indicates dynamic pressure and the blue line static
pressure. The blast overpressure duration (ms) was 4.1±0.3 (SEM) and the
overpressure integral (kPa*ms) was 75.2±4.5. Characteristics of the 74.5
and 116.7 kPa blast waves can be found in Ahlers et al. (2012).
Aβ 42 was decreased when compared to the control using an
unpaired t -test (p= 0.02) although this decrease did not reach
statistical significance when multiple comparisons were corrected
for using Dunnett’s test (p= 0.067). By contrast, the highest-
level exposure (116.7 kPa) did not affect levels of brain Aβ 42
at 24 h and affected Aβ 42 at 1 week only if multiple statistical
comparisons were ignored (Table 1). While a univariate ANOVA
indicated that Aβ 40 was also affected following blast exposure
(F6, 61= 4.936; p< 0.001), pairwise comparison of each experi-
mental blast condition to a matched control revealed that only the
74.5 exposure at 1 week was significantly lower than the control
(p= 0.006 Dunnett’s test).
NO EFFECT OF ORIENTATION TO THE BLAST WAVE ON Aβ LEVELS IN
RATS EXPOSED TO BLAST OVERPRESSURE INJURY
Since orientation to the blast wave might affect the brain’s response
due to alignment of long tracts or structural discontinuities, we
compared both frontal and side/lateral/perpendicular exposures
(Figure 3). A two-way ANOVA using blast exposure and orien-
tation as fixed variables did not reveal any interaction effect of
wave direction and orientation for either Aβ 40 (F4, 44= 0.979;
p= 0.42) or 42 (F4, 45= 1.102; p= 0.36). Pairwise comparisons
(unpaired t -tests) revealed no differences between the frontal and
side (lateral) orientations at any of the blast pressures tested, for
either Aβ 40 or 42. Thus, head/skull orientation to the blast wave
does not appear to affect the Aβ response in brain.
INCREASED LEVELS OF APP BUT NO EVIDENCE FOR ABNORMAL APP
STAINING OF AXONS IN RATS EXPOSED TO BLAST OVERPRESSURE
INJURY
Levels of APP expression increase acutely after experimental TBI
in rodents (Loane et al., 2009; Tian et al., 2012; Zhang et al., 2012).
To determine whether blast affects expression of APP, we examined
APP levels by quantitative Western blotting. Since the most consis-
tent changes in Aβ 42 were in the 36.6 kPa exposures, we compared
36.6 kPa blast exposure to their paired (non-blast exposed) con-
trols. We found APP levels were higher in blast exposed animals
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FIGURE 2 | Enzyme-linked immunosorbent assays for Aβ 40 (A,B)
and 42 (C,D) were performed onTriton X-100 brain extracts from rats
that were subjected to blast exposures of 36.6, 74.5, or 116.7 kPa and
harvested at 24 hours (24 h) or 1 week (1 wk) post-blast exposure.
Controls consisted of sham exposed rats harvested at 24 h (n=4) or
1 week (n=5) post-exposure. Because neither Aβ 40 (p=0.29, unpaired
t -test) nor 42 (p= 0.84) levels differed between the controls harvested at
24 h and 1 week, the two groups were pooled and treated as a single
control group (n=9). Numbers of samples in each group are indicated in
Table 1. Values are presented ± the SEM. Asterisk indicates values that
were significantly different from controls based on Dunnett’s test. Note
the decrease in Aβ 42 in rats exposed to a 36.6 kPa blast at 24 h and
1 week post-exposure as well as 74.5 kPa exposed rats at 24 h. By
contrast Aβ 40 was decreased in only the 74.5 kPa exposed rats at
1 week. Further statistical comparisons are discussed in the text and
presented inTable 1.
both 24 h (p= 0.05, unpaired t -test) and 1 week post-exposure
(p= 0.01; Figure 4). Thus, blast exposure increased APP levels
despite reductions in Aβ 42.
Amyloid precursor protein accumulation in axons is widely
used as a marker of axonal injury in both humans and experimen-
tal animal models of nbTBI (Gentleman et al., 1993; Sherriff et al.,
1994; Lewen et al., 1995; Pierce et al., 1996; Stone et al., 2000).
To determine whether abnormal axonal staining was present we
performed APP immunostaining on tissue harvested from blast
exposed rats at 24 h following a 74.5 kPa exposure comparing these
to sham exposed controls. Neither controls nor blast exposed rats
showed any evidence of axonal staining with APP (Figure 5).
UNCHANGED LEVELS OF BACE1 AND PRESENILIN-1 IN RATS EXPOSED
TO BLAST OVERPRESSURE INJURY
In experimental animal models of nbTBI, BACE1 (Blasko et al.,
2004; Chen et al., 2004; Loane et al., 2009; Zohar et al., 2011) along
with presenilin-1 (Chen et al., 2004; Nadler et al., 2008; Loane
et al., 2009), a component of the γ-secretase complex, have been
reported to be increased (Blasko et al., 2004; Chen et al., 2004;
Nadler et al., 2008; Loane et al., 2009; Zohar et al., 2011). However,
we did not find any changes in levels of either BACE1 (Figure 6)
or presenilin-1 (Figure 7) by Western blotting in rats subjected to
36.6 kPa blast exposures at 24 h or 1 week after exposure.
ACUTE DECREASES IN LEVELS OF Aβ IN MICE EXPOSED TO BLAST
OVERPRESSURE INJURY
We next determined whether similar changes might be found in
another rodent species. C57BL/6 mice were subjected to a single
147 kPa exposure, and the brains were harvested 24 h after expo-
sure. Both Aβ40 (p< 0.001,unpaired t -test) and Aβ42 (p< 0.001)
were significantly decreased in blast exposed mice, thus showing
that lowering of Aβ is likely a general response in rodent species
to acute blast (Figure 8).
DISCUSSION
Epidemiological studies support an association between single
incident severe TBI and the later development of AD (DeKosky
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Table 1 | Levels of abeta 40 and 42 in blast exposed rats.
N Mean SEM SD Dunnett’s test
vs. control
Unpaired t -test
vs. control
Aβ 40
Control 9 635.5 28.27 84.82 NA NA
36.6 kPa-24 h 5 607.0 31.88 71.28 0.99 0.53
36.6 kPa-1 week 10 676.6 28.00 88.54 0.88 0.31
74.5 kPa-24 h 18 564.2 31.83 135.0 0.32 0.16
74.5 kPa-1 week 8 468.1 31.04 87.79 0.006 0.001
116.7 kPa-24 h 9 684.3 36.37 109.1 0.80 0.30
116.7 kPa-1 week 9 625.8 11.78 35.35 1.00 0.75
Aβ 42
Control 9 37.03 1.437 4.311 NA NA
36.6 kPa-24 h 5 26.84 1.273 2.846 0.002 0.0005
36.6 kPa-1 week 10 29.29 2.096 6.627 0.005 0.008
74.5 kPa-24 h 18 29.46 1.086 4.606 0.002 0.0004
74.5 kPa-1 week 8 31.13 1.828 5.174 0.067 0.02
116.7 kPa-24 h 9 37.44 1.698 5.095 1.00 0.85
116.7 kPa-1 week 10 32.81 1.146 3.623 0.24 0.03
N, number; NA, not applicable; SEM, standard error of the mean; SD, standard deviation.
FIGURE 3 | Results of Aβ 40 (A–E) and 42 (F–J) ELISAs onTriton X-100
brain extracts are presented for rats exposed to frontal or side blast
exposures of 36.6 (A,F), 74.5 (B,C,G,H), or 116.7 kPa (D,E,I,J) harvested at
24 hours (24 h) or 1 week (1 wk) post-blast exposure. Values are presented
± the SEM. There were no statistically significant differences between any of
the pair wise comparisons (unpaired t -tests) demonstrating that orientation to
the blast had no effect on levels of Aβ 40 or 42. Further statistical tests are
discussed in the text. Sample sizes were: (A,F) (6 frontal and 4 side), (B,G) (8
frontal and 10 side), (C,H) (3 frontal and 5 side), (D,I) (5 frontal and 4 side), and
(E,J) (4 frontal and 5 side).
et al., 2010; Johnson et al., 2010). A variety of studies in humans as
well as experimental animals have documented the rapid appear-
ance of Aβ deposits and increased Aβ levels in the setting of acute
TBI (Ikonomovic et al., 2004; DeKosky et al., 2007; Abrahamson
et al., 2009; Loane et al., 2009, 2011; Tran et al., 2011; Tian et al.,
2012; Yu et al., 2012; Zhang et al., 2012) although none of these
studies have included subjects with blast injuries.
In this series of studies we determined effects of blast injury
on Aβ levels in rodent brain, using both rat and mouse mod-
els of blast-induced brain injury. Three blast levels in rats were
tested. Importantly prior studies using these models established
that exposures up to 74.5 kPa, while representing a blast level that
is transmitted to brain (Chavko et al., 2007), lead to no persistent
neurological impairments (Ahlers et al., 2012), nor result in gross
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FIGURE 4 | Western blotting was performed on hemi brainTriton
X-100 extracts from sham exposed (controls) or rats exposed to
36.6 kPa blast injury harvested at 24 h (A) or 1 week post-blast
exposure (B). The top panel in each set shows blotting with an antibody
that recognizes APP. In the lower panels the blots were reprobed for
β-tubulin (β-tub) as a loading control. Levels of APP are expressed as the
ratio of APP to β-tubulin (±SEM) for the experiments in (A) in (C,D) and
for (B) in (E,F). Asterisk indicates p=0.05 or less vs. control (unpaired
t -test). Note the increase in APP levels at both 24 h and 1 week
post-blast exposure.
neuropathological effects or lung pathology (Ahlers et al., 2012).
Thus, exposures of 36.6 or 74.5 kPa are consistent with those types
of blast that might be associated with mild TBI or subclinical
blast exposure. By contrast, moderate to severe TBIs are associated
with evident neuropathology as well as significant neurological
deficits and indeed 116.7 kPa blast exposures were often associ-
ated with transient loss of the righting reflex – which is believed
to approximate loss of consciousness in rodents as well as impair-
ment of motor and cognitive function (Ahlers et al., 2012). In
addition, approximately 30% of 116.7 kPa blast exposed animals
had gross cerebral and subdural hemorrhages as well as contu-
sions (Ahlers et al., 2012) and 116.7 kPa exposures also resulted in
significant lung pathology (Chavko et al., 2006, 2007; Ahlers et al.,
2012).
In our studies we showed that, in both rats and mice, blast
injury leads to diminished levels of Aβ 42 in rats and decreased
levels of both Aβ 40 and 42 in mice. Interestingly, the effect on Aβ
42 was most prominent in rats exposed to the lower blast expo-
sures (36.6 and 74.5 kPa), while there were no effects on Aβ 42 at
the 116.7 kPa exposure level. In mice, only a single blast exposure
of 147 kPa was tested. While it is difficult to directly compare blast
exposures in mice and rats, in mice this exposure is typically asso-
ciated with increased righting reflex time, weight loss, production
of reactive oxygen species, motor dysfunction and occasionally
mild cerebral hemorrhages and other neuropathology making it
more equivalent to a severe TBI (Wang et al., 2011). Such higher
blast pressures are also typically associated with lung pathology
that may worsen aspects of blast-associated brain injury by effects
mediated through the autonomic nervous system (Cernak, 2010).
Although, the converse may also be true, in that blast exposure to
the brain may contribute to lung pathology (Cernak, 2010).
Although prior studies have shown that a frontal orientation to
the blast wave is associated with more acute behavioral effects
(Ahlers et al., 2012), there was no effect of a frontal vs. lat-
eral (side) orientation on Aβ levels. There were also no con-
sistent effects on Aβ 40 levels in rats, with only the 74.5 kPa
exposure showing diminished levels 1 week post-exposure. While
Aβ 40 was also decreased by ≈15% in the one mouse expo-
sure, this decrease was much less than the ≈50% decline
seen in Aβ 42, suggesting that in both species the effect
of blast is much greater on Aβ 42 levels than on Aβ 40
levels.
Why Aβ typically increases acutely following TBI is not entirely
clear. The Aβ peptide itself is derived from processing of APP,
the larger precursor protein. In AD, the 39–42 amino acid Aβ
peptide deposits in senile plaques (Gandy, 2005). Many in vitro
and in vivo studies have demonstrated that in particular the
longer Aβ 42 species can be neurotoxic and that shunting of
APP processing toward Aβ 42 production sets off a chain of
pathological events (Gandy, 2005). Multiple studies in experi-
mental animals have found that APP expression increases acutely
following TBI (Murakami et al., 1998; Van Den Heuvel et al.,
2000; Ciallella et al., 2002; Chen et al., 2004). Simultaneously
there is increased expression of BACE1 as well as elements of
the γ-secretase complex (Blasko et al., 2004; Chen et al., 2004;
Nadler et al., 2008; Loane et al., 2009; Zohar et al., 2011) – all
of which would predict that there would be increased process-
ing of APP toward Aβ leading to great interest in the possi-
bility that similar neurotoxic mechanisms might be operative
in both AD and TBI. However, this would not explain the
results here since, despite increased APP levels, in rats sub-
jected to the 36.6 kPa blast exposure levels of Aβ 42 were
reduced.
The paradoxical elevation of APP in the setting of reduced Aβ
production might be explained by accumulation of unprocessed
APP in axons, and indeed, accumulation of APP in axons is used
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FIGURE 5 | Rats were exposed to 74.5 kPa or control (i.e., sham)
conditions and were sacrificed 24 h later. Sections from control
(A–C,G–I) and blast exposed (D–F,J–L) were immunostained with the
rabbit anti-APP antibody 369 (A,D,G,J) directed against the APP
C-terminus (green) and SMI-31 (B,E,H,K) a mouse monoclonal antibody
which recognizes phosphorylated epitopes on the mouse mid-sized and
heavy neurofilament proteins that are found mostly in axons (red).
Sections counterstained with a DAPI nuclear stain (blue) are shown in
(C,F,I,L). Staining in the corpus callosum (A–F) and layer 2 of the piriform
cortex (G–L) is shown. Note the lack of APP staining in the corpus
callosum (CC) in either blast exposed or control and the fine axonal
staining with SMI-31 which is indicated by arrows in (B,E,H,K) that is
present in both blast and control. Staining of neurons (arrows) in layer 2
of the piriform cortex is shown as a positive control for staining with the
anti-APP antibody (G,J). The margins of layer 2 are indicated by broken
lines in (I,L). Scale bar: 10µm.
widely as a marker of axonal injury in both humans and exper-
imental animal models of TBI (Gentleman et al., 1993; Sherriff
et al., 1994; Lewen et al., 1995; Pierce et al., 1996; Stone et al.,
2000). However, while one study has reported APP accumulation
in axons following blast exposure (Kuehn et al., 2011), others have
not (Garman et al., 2011; Pun et al., 2011; Risling et al., 2011;
Ahlers et al., 2012). Risling et al. (2011), for example, noted no
APP accumulation in axons of rats exposed to 130 and 260 kPa
exposures. Garman et al. (2011) studied rats exposed to greater
than 240 kPa (35 psi) blast exposures and found widespread evi-
dence of DAI by silver staining. However, despite evidence of
extensive axonal injury by silver staining, APP-stained sections
typically showed only minimal axonal staining, except for rats
studied at 24 h post-exposure where some mild axonal staining
was evident within the deep cerebellar white matter and adja-
cent to some foci of acute neuronal degeneration. Interestingly,
Pun et al. (2011) although not commenting on axonal staining
did note more APP positive cells in the white matter of rats
at 1 day following blast exposures of 48.9 or 77.3 kPa which are
quite similar to those studied here. However, in the present stud-
ies we did not observe any axonal staining with APP or any
obvious alteration in perikaryal staining in blast exposed rats.
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FIGURE 6 | Western blotting was performed on hemi brainTriton
X-100 extracts from sham exposed (controls) or rats exposed to
36.6 kPa blast injury harvested at 24 h (A) or 1 week post-blast
exposure (B). The top panel in each set shows blotting with an
antibody that recognizes BACE1. In the lower panels the blots were
reprobed for β-tubulin (β-tub) as a loading control. Levels of BACE1
are expressed as the ratio of BACE1 to β-tubulin (±SEM) for the
experiments in (A) in (C,D) and for (B) in (E,F). Note the lack of
change in BACE1 levels in rats exposed to a 36.6 kPa blast at either
24 h or 1 week.
FIGURE 7 | Western blotting was performed on hemi brain SDS extracts
from sham exposed (controls) or rats exposed to 36.6 kPa blast injury
harvested at 24 h (A) or 1 week post-blast exposure (B). Blotting was
performed with an antibody that recognizes presenilin-1 (PS1) and the blots
were reprobed for β-tubulin (β-tub). Levels of presenilin-1 are expressed as the
ratio of presenilin-1 to β-tubulin (±SEM) for the experiments in (A) in (C,D)
and for (B) in (E,F). Note the lack of change in PS1 levels in rats exposed to a
36.6 kPa blast at either 24 h or 1 week.
FIGURE 8 | Enzyme-linked immunosorbent assays for Aβ 40 (A,B) and 42
(C,D) were performed on total brain extracts from mice exposed to blast
injuries of 147 kPa and harvested at 24 h post-blast exposure. Controls
consisted of sham exposed mice. Values are presented the ±SEM. Asterisk
indicates values that were significantly different from controls (unpaired
t -tests). Note the reduction in Aβ 40 and 42.
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Thus pure blast exposure does not appear to induce accumu-
lation of APP in axons in the consistent fashion apparent in
nbTBI.
Future studies will be needed to elucidate the mechanism
underlying the acute effects of blast exposure on Aβ production.
These studies have practical implications for the treatment of acute
blast injury, since blocking Aβ production by a variety of phar-
macological or genetic means has been reported to reduce tissue
damage acutely and improve outcome following controlled corti-
cal impact injuries (CCI) in mice (Abrahamson et al., 2009; Loane
et al., 2009, 2011). However, the studies reported here suggest that
such strategies may not be applicable to treatment of acute blast
injuries.
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APPENDIX
FIGURE A1 | Non-blast exposed control rats were sacrificed and
hemibrains were fractioned intoTris buffered saline soluble,Triton
X-100 soluble, and formic acid-extractable fractions. Levels of Aβ 40
(A,B) were determined by ELISA. Values are presented the ±SEM.
Univariate ANOVA indicated that Aβ 40 levels differed between the fractions
(F 2, 12 =4.936; p< 0.001). Post-test comparisons between the groups are
indicated (Tukey’s multiple comparisons test). NS indicates not significant.
Note that most Aβ 40 is found in the Triton X-100 soluble fraction.
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